Health & MedicineScience
Linafexor: A Paradigm Shift in Drug Design for Liver Disease
Chinese scientists develop Linafexor, a first-in-class pulsed FXR agonist for bile acid disorders, shifting from sustained to rhythmic drug activation.
—6 min read
Category
2 articles
Chinese scientists develop Linafexor, a first-in-class pulsed FXR agonist for bile acid disorders, shifting from sustained to rhythmic drug activation.
China releases updated GCP standards for drug clinical trials, adding a new data governance chapter and aligning with international best practices.